Amgen, Inc. is a biotechnology company that specializes in the discovery, development, manufacture, and marketing of human therapeutics. Founded on April 8, 1980, by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld, the company is headquartered in Thousand Oaks, CA.
Notable Products and Research Areas
Amgen, Inc. has developed several notable products, including:
-Enbrel (etanercept), a treatment for rheumatoid arthritis and psoriatic arthritis
- Neulasta (pegfilgrastim), a medication for preventing chemotherapy-induced neutropenia
- Prolia (denosumab), a treatment for osteoporosis
The company also conducts research in various areas, including:
-Cancer treatment and therapy
-Cardiovascular disease
-Neurology and neuroscience
-Inflammation and immunology
Notable Products and Research Areas
Amgen, Inc. has developed several notable products, including:
-Enbrel (etanercept), a treatment for rheumatoid arthritis and psoriatic arthritis
- Neulasta (pegfilgrastim), a medication for preventing chemotherapy-induced neutropenia
- Prolia (denosumab), a treatment for osteoporosis
The company also conducts research in various areas, including:
-Cancer treatment and therapy
-Cardiovascular disease
-Neurology and neuroscience
-Inflammation and immunology
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.